A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers
Completed
Conditions studied: Pancreatic Cancer, Bile Duct Cancer
In brief
This registry will collect data from patients routinely undergoing an ERCP and Cellvizio endomicroscopy procedure (and optionally an additional cholangiopancreatoscopy procedure) due to suspected pancreatic or bile duct cancer. The objective is to determine if endomicroscopy images collected using the marketed Cellvizio device may help endoscopists more accurately diagnose, in conjunction with traditional tissue sampling techniques, whether a suspected lesion is malignant or benign.
Key facts
- Study ID
- NCT00779688
- Run by
- Mauna Kea Technologies
- People needed
- 130
- Starts
- 2008-11-01
- Expected to finish
- 2010-10-01
- Last updated by the study team
- 2011-02-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female > 18 years of age
- Willing and able to comply with Registry procedures and provide written informed consent to participate in the Registry
- Indicated for ERCP and/or cholangiopancreatoscopy
- Indeterminate or suspected biliary and/or pancreatic stricture, mass, or neoplasm
You may not qualify if…
- Subjects for whom ERCP procedures are contraindicated
- Known allergy to fluorescein dye
Where it is running
- University of Colorado Hospital — Aurora, Colorado, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- New York Presbyterian Hospital/Columbia University Medical Center — New York, New York, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Institut Paoli-Calmettes — Marseille, France
- Klinikum rechts der Isar — Munich, Bavaria, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.